Factors Predicting the Efficacy of Adefovir Dipivoxil on Treatment-Naïve Chronic Hepatitis B Patients at 48 Weeks

BACKGROUND/AIMS: To reveal possible factors predicting the effect of adefovir dipivoxil (ADV) treatment on chronic hepatitis B (CHB) and optimize the utilization of ADV. METHODS: In total, 168 treatment-naïve CHB patients were enrolled, including 117 hepatitis B e antigen (HBeAg)-positive patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li-Chun, Chen, En-Qiang, Zhu, Xiao-Feng, Xiong, Zhong-Hua, Liu, Li, Xu, Lu, Lei, Xue-Zhong, Liu, Cong, Tang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240792/
https://www.ncbi.nlm.nih.gov/pubmed/22195247
http://dx.doi.org/10.5009/gnl.2011.5.4.478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240792/
https://www.ncbi.nlm.nih.gov/pubmed/22195247
http://dx.doi.org/10.5009/gnl.2011.5.4.478

Ejemplares similares